This is a preview of subscription content, log in via an institution to check access.
REFERENCE
Provan D, Bussel JB, Cheng G, Grotzinger KM, Duh M, Signorovitch J, Stone NL, Aivado M.Improvement in fatigue and health-related quality of life with long-term eltrombopag therapy in chronic idiopathic thrombocytopenic purpura: results of phase 3, double-blind study (RAISE). 14th Congress of the European Hematology Association: 92 abstr. 0233, 4 Jun 2009. Available from: URL: http://online.haematologica.org/meetings
Rights and permissions
About this article
Cite this article
Eltrombopag RAISEs the bar in ITP. Pharmacoecon. Outcomes News 584, 9 (2009). https://doi.org/10.2165/00151234-200905840-00022
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200905840-00022